[
    {
        "molecule_name": "Eptifibatide",
        "protein_target_name": "glycoprotein IIb/IIIa",
        "binding_metric": "Kd",
        "value": "0.1-10,000",
        "unit": "Nanomolar",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nConcentration(Nanomolar):Class of AgentDrugTherapeuticPreferredMost PreferredSerotonin<sub>2</sub>LY 53857 0.1-500   1-10050antagonist\nConcentration(Nanomolar):Class of AgentDrugTherapeuticPreferredMost PreferredHistamine<sub>1</sub>terfenadine 0.1-1,000   50-500200antagonist\nConcentration(Nanomolar):Class of AgentDrugTherapeuticPreferredMost Preferredcyclooxygenaseketorolac 100-10,000  500-5,0003,000inhibitor\nConcentration(Nanomolar):Class of AgentDrugTherapeuticPreferredMost Preferredneurokinin<sub>2</sub>SR 48968  1-1,000   10-500200antagonist\nConcentration(Nanomolar):Class of AgentDrugTherapeuticPreferredMost Preferredpurine<sub>2X </sub>antagonistPPADS 100-100,00010,000-100,00050,000\nConcentration(Nanomolar):Class of AgentDrugTherapeuticPreferredMost PreferredATP-sensitive K<sup>+</sup>(−) pinacidil  1-10,000  100-1,000500channel agonist\nConcentration(Nanomolar):Class of AgentDrugTherapeuticPreferredMost PreferredCa<sup>2+</sup> channelnifedipine  1-10,000  100-5,0001,000antagonist\nConcentration(Nanomolar):Class of AgentDrugTherapeuticPreferredMost Preferredkallikrein inhibitoraprotinin 0.1-1,000   50-500200\nConcentration(Nanomolar):Class of AgentDrugTherapeuticPreferredMost Preferrednitric oxide donorSIN-1  10-10,000  100-1,000500\nConcentration(Nanomolar):MostClass of AgentDrugTherapeuticPreferredPreferredthrombin inhibitorhirulog0.2-20,000 2-2,000  200\nConcentration(Nanomolar):MostClass of AgentDrugTherapeuticPreferredPreferredglycoprotein IIb/IIIaintegrelin0.1-10,000 × Kd 1-1000 × Kd  100 × Kdreceptor blocker\nConcentration(Nanomolar):MostClass of AgentDrugTherapeuticPreferredPreferredPKC inhibitorGF 109203X*0.1-10,000 1-1,000  200\nConcentration(Nanomolar):MostClass of AgentDrugTherapeuticPreferredPreferredprotein tyrosinetyrphostin 10-100,000100-20,00010,000kinase inhibitor\nConcentration(Nanomolar):MostClass of AgentDrugTherapeuticPreferredPreferredAG1296\nConcentrationClass of(Nanomolar):MostAgentDrugTherapeuticPreferredPreferredNO donorFK 409 (NOR-3) 1-1,000 10-500250\nConcentrationClass of(Nanomolar):MostAgentDrugTherapeuticPreferredPreferredNO donorFR 14442010-10,000100-5,0001,000\nConcentrationClass of(Nanomolar):MostAgentDrugTherapeuticPreferredPreferredH<sub>1 </sub>antagonistmepyramine0.1-1,000 5-200100\nConcentrationClass of(Nanomolar):MostAgentDrugTherapeuticPreferredPreferredbradykinin<sub>1</sub>[leu<sup>9</sup>][des-Arg<sup>10</sup>]0.1-50010-200100\nConcentrationClass of(Nanomolar):MostAgentDrugTherapeuticPreferredPreferredkallidenbradykinin<sub>2</sub>HOE 140  1-1,00050-500200"
    }
]